MaxCyte CFO Douglas Swirsky to Step Down in 2026

Reuters11-13
MaxCyte CFO Douglas Swirsky to Step Down in 2026

MaxCyte Inc. announced that Chief Financial Officer Douglas Swirsky will transition from his role in the first half of 2026. The company has begun searching for his successor. Swirsky will remain CFO until a replacement is appointed and will then serve in an advisory capacity to support the transition. The company expects no impact on its operations or strategic priorities during this period.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MaxCyte Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9574469-en) on November 12, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment